180 related articles for article (PubMed ID: 18455881)
1. Blockade of M1 muscarinic acetylcholine receptors modulates the methamphetamine-induced psychomotor stimulant effect.
Lee KW; Tian YH; You IJ; Kwon SH; Ha RR; Lee SY; Kim HC; Jang CG
Neuroscience; 2008 Jun; 153(4):1235-44. PubMed ID: 18455881
[TBL] [Abstract][Full Text] [Related]
2. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
3. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice.
Ago Y; Nakamura S; Kajita N; Uda M; Hashimoto H; Baba A; Matsuda T
Synapse; 2007 Sep; 61(9):757-63. PubMed ID: 17568413
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
[TBL] [Abstract][Full Text] [Related]
5. Role of tissue plasminogen activator in the sensitization of methamphetamine-induced dopamine release in the nucleus accumbens.
Fukakusa A; Nagai T; Mizoguchi H; Otsuka N; Kimura H; Kamei H; Kim HC; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2008 Apr; 105(2):436-44. PubMed ID: 18036193
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
7. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
8. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
Cass WA
J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
[TBL] [Abstract][Full Text] [Related]
9. Effect of acute and chronic treatment with methamphetamine on mRNA expression of synaptotagmin IV and 25 KDa-synaptic-associated protein in the rat brain.
Isao T; Akiyama K
Psychiatry Clin Neurosci; 2004 Aug; 58(4):410-9. PubMed ID: 15298655
[TBL] [Abstract][Full Text] [Related]
10. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53.
Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP
Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780
[TBL] [Abstract][Full Text] [Related]
11. mRNA expression of the Nurr1 and NGFI-B nuclear receptor families following acute and chronic administration of methamphetamine.
Akiyama K; Isao T; Ide S; Ishikawa M; Saito A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1957-66. PubMed ID: 18930103
[TBL] [Abstract][Full Text] [Related]
12. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T
Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526
[TBL] [Abstract][Full Text] [Related]
13. Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum.
Wu PH; Shen YC; Wang YH; Chi CW; Yen JC
Toxicology; 2006 Sep; 226(2-3):238-45. PubMed ID: 16887252
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.
Narita M; Miyatake M; Shibasaki M; Tsuda M; Koizumi S; Narita M; Yajima Y; Inoue K; Suzuki T
J Neurochem; 2005 Jun; 93(6):1383-92. PubMed ID: 15935054
[TBL] [Abstract][Full Text] [Related]
15. Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice.
Kamei H; Nagai T; Nakano H; Togan Y; Takayanagi M; Takahashi K; Kobayashi K; Yoshida S; Maeda K; Takuma K; Nabeshima T; Yamada K
Biol Psychiatry; 2006 Jan; 59(1):75-84. PubMed ID: 16139811
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine.
Ares-Santos S; Granado N; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2012 Feb; 45(2):810-20. PubMed ID: 22115942
[TBL] [Abstract][Full Text] [Related]
17. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
18. Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity.
Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
Synapse; 2009 Jan; 63(1):7-14. PubMed ID: 18925659
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain.
Gonçalves J; Martins T; Ferreira R; Milhazes N; Borges F; Ribeiro CF; Malva JO; Macedo TR; Silva AP
Ann N Y Acad Sci; 2008 Oct; 1139():103-11. PubMed ID: 18991854
[TBL] [Abstract][Full Text] [Related]
20. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine.
Witkin JM; Savtchenko N; Mashkovsky M; Beekman M; Munzar P; Gasior M; Goldberg SR; Ungard JT; Kim J; Shippenberg T; Chefer V
J Pharmacol Exp Ther; 1999 Mar; 288(3):1298-310. PubMed ID: 10027871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
